Tvardi Therapeutics (TVRD) Return on Equity [ROE] (2014 - 2026)
Tvardi Therapeutics' Return on Equity [ROE] came in at -227.75% for Q2 2026, down 69.24 percentage points from the prior quarter.
Powered by 
Analysis
Tvardi Therapeutics (TVRD) Return on Equity [ROE] (2014 - 2026) Analysis & Trends
For FY2023, Tvardi Therapeutics' Return on Equity [ROE] was -245.06%, down 200.81 percentage points from FY2022.
- Return on Equity [ROE] has declined in each of the last three years, with a five-year change of -177.90 percentage points (FY2018 to FY2023).
- Going back by year, Return on Equity [ROE] was -44.25% in FY2022 (-7.13 pp), -37.12% in FY2021 (-40.98 pp), 3.86% in FY2020 (+70.27 pp) and -66.41% in FY2019 (+0.75 pp).
- The Q2 2026 figure represents the lowest quarterly Return on Equity [ROE] since Q4 2023.
- The fastest year-over-year change in Return on Equity [ROE] over five years came in Q3 2021 (a gain of 85.36 percentage points), and the weakest in Q4 2023 (a drop of 979.37 percentage points).
- Business Quant data shows TVRD's Return on Equity [ROE] at -158.52% (Q1 2026), -103.96% (Q4 2025) and -94.64% (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROE (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn | 82.09% |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn | 25.32% |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn | - |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn | 7.21% |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn | 84.40% |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn | 21.39% |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn | 83.75% |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn | -18.38% |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn | 4.97% |
| 10 | Tvardi Therapeutics | 10.79 Mn | 10.79 Mn | - | -227.75% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -227.75% |
| Mar 31, 2026 | -158.52% |
| Dec 31, 2025 | -103.96% |
| Sep 30, 2025 | -94.64% |
| Dec 31, 2023 | -1,030.32% |
| Sep 30, 2023 | -123.55% |
| Jun 30, 2023 | -93.79% |
| Mar 31, 2023 | -59.09% |
| Dec 31, 2022 | -50.95% |
| Sep 30, 2022 | -46.04% |
| Jun 30, 2022 | -32.69% |
| Mar 31, 2022 | -43.12% |
| Dec 31, 2021 | -40.69% |
| Sep 30, 2021 | 11.62% |
| Jun 30, 2021 | 3.85% |
| Mar 31, 2021 | 5.85% |
| Dec 31, 2020 | 4.46% |
| Sep 30, 2020 | -73.75% |
| Jun 30, 2020 | -76.60% |
| Mar 31, 2020 | -65.29% |
API Access
Tvardi Therapeutics Return on Equity [ROE] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=TVRD&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-equity-[roe]", "ticker": "TVRD", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=TVRD&period=max&api_key=YOUR_API_KEY");
const data = await res.json();